DAVID ROWLEY to Carcinoma, Transitional Cell
This is a "connection" page, showing publications DAVID ROWLEY has written about Carcinoma, Transitional Cell.
Connection Strength
0.077
-
Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urol Oncol. 2003 May-Jun; 21(3):197-205.
Score: 0.046
-
Adenovirus-mediated suicide gene therapy for experimental bladder cancer. Urology. 1997 Feb; 49(2):173-80.
Score: 0.030